C-19393 S2 and H2 are new carbapenem antibiotics with a broad antibacterial spectrum, produced by Streptomyces griseus subsp. cryophilus1). Chemical studies2) established their structures to be those shown in Fig, 1 . They had high affinity for penicillin-binding protein 2 of Escherichia coli, and inhibited peptidoglycan biosynthesis of the same organism3). They also acted synergistically with ampicillin and cefotiam against j3-lactamase producing bacteria1), and their strong interactions with j9-lactamases were expected. The present report describes the jS-lactamase inhibitory properties of these new antibiotics. 
Materials and Methods
Antibiotics C-19393 S2 and H2 were prepared from the culture broth of Streptomyces griseus subsp. cryophilus as described2). Clavulanic acid lithium salt was prepared in our research division. Ampicillin (Takeda Chemical Industries, Ltd.), benzylpenicillin (Meiji Seika Kaisha, Ltd.), dicloxacillin (Banyu Pharmaceutical Co., Ltd.) and cephalothin (Shionogi & Co., Ltd.) were commercial products.
S-Lactamase preparations 3-Lactamases of Escherichia coli TN713, E. coli TN649 and Pseudomonas aeruginosa GN3407 are plasmid-mediated, constitutive enzymes, and that of Klebsiella pneumoniae TN1698 is a constitutive enzyme. The j3-lactamase of Staphylococcus aureus 1840 is an inducible one (induced by 0.5 uyg/ml dicloxacillin), as are those of Citrobacter freundii GN1706, P. aeruginosa U31, Serratia marcescens TN81, Proteus vulgaris GN4413 and Enterobacter cloacae TN1282 (induced by 1 mg/ml benzylpenicillin).
The enzymes were prepared as follows. An overnight culture was diluted 10-fold into 250 ml of Trypticase soy broth (BBL) in a 1,000 ml flask and the flask was shaken for 3 hours on a rotary shaker at 37°C. Inducer was added, if necessary, and the organism was grown for another 2 hours. The cells were harvested from 5 liter of the culture by centrifugation, suspended in 500 ml of phosphate 213 VOL. XYXIV NO. 2 THE JOURNAL OF ANTIBIOTICS buffer (0.05 M, pH 6.9), and sonically disrupted by a ultrasonic oscillator (Kaijo Denki Co., Ltd.) in an ice bath. Cell debris was discarded by centrifugation and the enzyme was purified from the supernatant fluid. The (3-lactamase of S. aureus 1840 was purified through phospho-cellulose column chromatography as described by RICHMOND4) ; those of P. vulgaris GN4413 and E. cloacae TN 1282 through CM Sephadex C-50 column chromatography and Sephadex G-100 gel filtration according to the method described by HENNESSEY et al.5) ; those of E. coli TN713, E. coli TN649 and P. aeruginosa GN3407 through DEAE cellulose column chromatography and Sephadex G-100 gel filtration as described by OGAWARA et a1.6) The enzymes of K. pneumoniae TN1698, C. freundii GN1706, P. aeruglnosa U31 and S. marcescens TN81 were purified as was the E. coli TN713 enzyme, by the use of CM cellulose instead of DEAE cellulose. The Bacteroides fragilis V284-3 (3-lactamase, which was precipitated by between 50 and 70% saturation of ammonium sulfate, was a generous gift of Dr. T. KOHATA (Gifu University). Assay of /3-lactamase inhibition and determination of I50 values B-Lactamase activity was determined by the modification of microiodometric method of NovicK.7) Ampicillin was used as substrate for penicillinase assay and cephalothin for cephalosporinase assay. A solution of an inhibitor (0.05 ml) was added to 0.002 units of a (3-lactamase in 0.9 ml of phosphate buffer (0.05 M, pH 6.9), and the mixture was incubated at 30°C for 10 minutes unless otherwise stated. A substrate in 0.05 ml of phosphate buffer was then added to the preincubated mixture to give a final concentration of 0.1 mM, and the incubation was continued for another 10 minutes. The reaction was stopped by the addition of 0.5 ml of 0.15 M sodium tungstate in acetate buffer (2.0 M, pH 4.0). Each sample had a control in which substrate and inhibitor were incubated, enzyme being added after adding the tungstate. Then 1.5 ml of an iodine-starch solution (0.1 mM iodine, 1.6 mM potassium iodide, 0.4% starch and 0.04 M potassium phosphate buffer pH 6.0) was added. After 15 minutes or more at room temperature, absorbance was read at 620 nm in a Hitachi spectrophotometer.
The enzyme activity was calculated from the differences in absorbance between control and experiment; 1 absorbance unit was equivalent to 0.0300 umole of ampicillin and 0.0475 umole of cephalothin hydrolyzed, respectively. One unit (U) of penicillinase or cephalosporinase is defined as the amount of enzyme that hydrolyzes 1 umole of ampicillin or cephalothin, respectively, per minute at 30°C.
Percentage inhibition of enzyme activity was calculated against a control reaction where inhibitor was replaced by buffer. The concentration of inhibitor giving 50% inhibition (I50) was calculated from a plot of the percentage inhibition against the inhibitor concentration.
Gel filtration of i3-lactamase incubated with inhibitor The E. coli TN713 13-lactamase (0.2 U) was incubated at 30°C with 1 ug of C-19393 S2, 50 ug of C-19393 H2 or 100 ug of clavulanic acid in 1 ml of phosphate buffer (0.05 M, pH 6.9). After 10 minutes incubation, 0.5 ml of the mixture was applied to a column (1.3 x 28 cm) of Sephadex G-25 at 4°C. The column was eluted with the same phosphate buffer at 10 ml per hour and 1 ml fractions were collected. Enzyme activity was determined microiodometrically.
Fractions eluted after the peak of enzyme activity were assayed for the inhibitor by using inhibition of E. coli TN713 j3-lactamase.
Results

j3-Lactamase Inhibitory Activity
The inhibitory activities, I50s, of C-19393 S2, C-19393 H2 and clavulanic acid against various j3-lactamases were determined under the conditions described in Materials and Methods. As shown in Table 1 , both C-19393 S2 and H2 inhibited a wide range of (3-lactamases at very low concentrations.
Enzymes inhibited by C-19393 S2 and H2 included cephalosporinases which were insensitive to clavulanic acid. Enzymes that were especially well inhibited by C-19393 S2 and H2 were plasmid-mediated type I and type II penicillinases8), K. pneumoniae TN1698 penicillinase and cephalosporinases from P. vulgaris GN4413, S. marcescens TN81 and B. fragilis V284-3. The relative inhibitory activities of C-19393 S2 and H2 were variable, depending on the enzyme tested. Against S. marcescens TN81 j3-lactamase, C-19393 H2 was 100 times more active than C-19393 S2, whereas against E. coli TN713 B-lactamase, C-19393 H2 was 10 times less active than C-19393 S2.
Progressive and Non-progressive Inhibition of 3-Lactamase The enzyme activity remaining after various times of preincubation of 3-lactamase with inhibitor Table 1 ) were chosen for these experiments. As shown in Fig. 2 , C-19393 S2 inhibited both E. coli TN713 and P.
vulgaris GN4413 3-lactamases in a progressive fashion. On the other hand, inhibitory activity of C-19393 H2 against E. coli TN713 jS-lactamase did not change during preincubation periods of up to 1 hour. P. vulgaris GN4413 /3-lactamase was inhibited by C-19393 H2 progressively at first, then the enzyme activity was gradually recovered. In this experiment, the molar ratio of the P. vulgaris enzyme and C-19393 H2 was approximately 1: 8. Under the condition of this enzyme/inhibitor concentration ratio, C-19393 H2 lost its antibacterial activity within 10 minutes of incubation. 3-Lactamases from S. aureus 1840, E. cloacae TN1282 and S. marcescens TN81 were inhibited progressively by both C-19393 S2 and H2 (data not shown).
Reversible and Irreversible Inhibition of 3-Lactamase
In order to elucidate how the natures of inhibition by C-19393 S2 (progressive) and C-19393 H2
(non-progressive) of the E. coli TN713 3-lactamase differ, we analyzed the reversibility of the inhibition by those two antibiotics. The reversibility of the inhibition by clavulanic acid which is a pro- Fig. 3 . Gel filtration of E. coli TN713 jl-lactamase incubated with inhibitors. The enzyme (0.2 U/ml) was incubated with 1 cg of C-19393 S2 (A), 50 ug of C-19393 H2 (B) or 100 ug of clavulanic acid (C) per ml at 30`C for 10 minutes. A 0.5 ml portion of the mixture was applied to a column of Sephadex G-25 (1.3 x 28 cm) and eluted with phosphate buffer (0.05 M, pH 6.9). Fractions (1ml) were assayed for enzyme and inhibitor activities as described in Materials and Methods.
gressive inhibitor of the fi-lactamase10) was also examined. The enzyme was incubated with a large excess of C-19393 S2, C-19393 H2 or clavulanic acid at 30°C for 10 minutes and the mixture was applied to gel-filtration as described in Materials and Methods. As shown in Fig. 3 , when the enzyme was reacted with C-19393 S2, only 4% of the activity was recovered after the gel-filtration, whereas with C-19393 H2 all the activity was recovered. Recovery of enzyme activity incubated with clavulanic acid was 39%. All the inhibitory activities of both C-19393 S2 and H2 were recovered after the gel filtration. Recovery of clavulanic acid was slightly low.
Discussion
Both C-19393 52 and H2, at very low concentration, inhibited all of the 11 types of the 13-lactamases tested. They also inhibited cephalosporinases which were insensitive to clavulanic acid10). Inhibitory activities of C-19393 S2 and H2 against most f3-lactamases were far stronger than that of clavulanic acid. C-19393 S2 is a methylated compound of antibiotic MM 455011) and C-19393 H2 is a desulfo derivative of C-19393 S2. I50 values of C-19393 S2 and H2 against several 3-lactamases were almost the same as or slightly lower than that of MM 4550 reported by HOOD et al12), although exact comparison is difficult because of differences in the assay method and the source of enzyme. The synergistic activities of C-19393 S2 and H2 with ampicillin and cefotiam against 13-lactamase producing bacteria1) were apparently due to the 3-lactamase inhibitory activities of the drugs.
The inhibitory activity of C-19393 S2 against E. coli TN713 3-lactamase was 10 times as great as that of C-19393 H2, whereas C-19393 H2 was 100 times more active in its ability to inhibit S. marcescens TN81 3-lactamase than C-19393 S2. This difference in the relative inhibitory activities between C-19393 S2 and H2 against the two enzymes can be used for differential determination of the drugs in culture broth of the producing organism, which produces the two antibiotics simultaneously1).
C-19393 S2 inhibited all (3-lactamases tested in progressive fashion, and C-19393 H2 was also a progressive inhibitor of j3-lactamases from S. aureus 1840, E. cloacae TN1282, S. marcescens TN81 and P. vulgaris GN4413. However, the inhibition of E. coli TN713 j3-lactamase by C-19393 H2 was not progressive. Gel filtration clearly revealed that C-19393 S2 inhibited E. coli TN713 j3-lactamase irreversibly but that the inhibition by C-19393 H2 was reversible. Clavulanic acid also exerted an irreversible inhibition, though its extent was partial. This indicates that the binding of clavulanic acid is less tight than that of C-19393 S2.
C-19393 H2 inhibited P, vulgaris GN4413 3-lactamase progressively for a few minutes, but the enzyme activity was recovered gradually by prolonged incubation. This phenomenon is also observed with clavulanic acid13) and PS-514). The regeneration of the enzyme activity and the data suggesting a slow hydrolysis of C-19393 H2 (data not shown) indicate that this compound is also a substrate for P. vulgaris j3-lactamase, as are clavulanic acid and PS-5.
